SHANGHAI, Feb 9 (Reuters) - China's Innovent Biologics has struck a new deal with Eli Lilly to develop immunology and oncology drugs, under which the U.S. drugmaker will pay $350 million upfront and ...

The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and ...

Indian Pharmacopoeia Commission inks 3 MoUs to boost drug safety, quality standards ...

A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...

Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...

Eli Lilly is heading back to its regular Chinese collaborator Innovent Biologics with $350 million in upfront cash to collaborate on new meds for patients with cancer or immune disorders. | Eli Lilly ...

According to the Washington Post (WP) and others on the 4th, local time, Fiji—with a population of less than 1 million—has ...

DUBAI, 8th February, 2026 (WAM) -- The Emirates Drug Establishment (EDE) is all set to participate in the World Health Expo 2026 (WHX), taking place at Expo City Dubai, where it will be showcasing a ...

Ascentage Pharma will be conducting a multicenter, open-label Phase I study designed to evaluate the safety, tolerability, pharmacokinetic (PK) profile, and preliminary efficacy of APG-3288 in ...

At the India Today Education Conclave 2026, Amit Sen warned that excessive screen use is worsening children’s mental health.

DUBAI, 9th February, 2026 (WAM) -- The World Health Expo (WHX) 2026 kicked off Monday at the Dubai Exhibition Centre in Expo City Dubai. The Ministry of Health and Prevention, alongside national and ...